ATF4 depletion leads to the reduction of metastasis, cancer stemness, and tumor survival in vitro and in vivo and is involved in the TGFβ/SMAD and PI3K/mTOR pathways, playing growth factor-dependent functions. The gene discussed is MTOR; the disease is cancer.